Advances in the Management of
Intracerebral Hemorrhage:
Evolving Scientific Evidence for
Critical-Care Pharmacists
Sunday, December 3, 2006 • 10 a.m. – 12 p.m.
Anaheim Marriott Hotel • Marquis Ballroom NorthWest
Anaheim, California
Program Description
Accounting for more than 10% of all strokes in the United States, intracerebral hemorrhage (ICH) is particularly devastating because it is associated with high morbidity and mortality despite clinical intervention. Understanding the latest science in the management of patients with ICH is important to health-system pharmacists, especially clinical specialists practicing in critical care areas within the hospital.
Many patients with ICH experience an increase in hematoma volume due to subsequent bleeding, and the increase in hematoma volume is an important predictor of mortality and neurological and functional outcomes in these patients. Conventional management of patients with ICH focuses on controlling the intracranial pressure, preventing seizures, limiting cerebral injury, and preventing complications. Recent advances have led to medical therapy that limits hematoma growth, reduces mortality, and improves functional outcomes in patients with ICH.
This symposium will provide an overview of ICH, including morbidity and mortality, risk factors for development of ICH, and prognostic indicators. The objectives of conventional medical and surgical interventions for ICH will be discussed, and recent medical advances will be presented. Speakers will also provide insight into ICH treatment guideline development.
Target Audience
This symposium was planned to meet the needs of practitioners, scientists, educators, administrators, students, residents, fellows, and others committed to excellence in clinical pharmacy and patient pharmacotherapy. The program is beneficial for pharmacists who participate in the care of patients with intracerebral hemorrhage and for those who want to keep informed on emerging therapies.
Sign up now for this symposium! »Register
